Emergent BioSolutions Inc. Common Stock — Cash Flow (NYSE:EBS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 536 M321.1 M-34.1 M-206.3 M58.7 M170.6 M 148 M Cash from investing activities -151 M-225 M-381.3 M212.3 M125.2 M69.4 M 7.5 M Cash from financing activities 69.5 M-141 M481.2 M-535.7 M-190 M-136.6 M -147.6 M Free cash flow 536 M321.1 M-34.1 M-206.3 M58.7 M170.6 M 148 M

News

Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come (NYSE:EBS)

Emergent BioSolutions Inc. (EBS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks Transcript

Emergent BioSolutions Inc. 2026 Q1 - Results - Earnings Call Presentation (NYSE:EBS) 2026-05-02

Emergent BioSolutions Inc. (EBS) Q1 2026 Earnings Call Transcript

Siga Technologies: No News (On BARDA Contract) Not Necessarily Good News (NASDAQ:SIGA)

H.C. Wainwright cuts Emergent BioSolutions stock price target on revenue miss

Emergent BioSolutions Earnings: Revenue, Margins And GAAP Losses Paint Mixed Picture (EBS)

Netflix, Dell among market cap stock movers on Friday

Netflix and Dell among market cap stock movers on Friday

Emergent BioSolutions Inc. (EBS) Q4 2025 Earnings Call Prepared Remarks Transcript

Emergent BioSolutions Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:EBS) 2026-02-26

Emergent BioSolutions Q4 2025 slides: transformation advances despite revenue miss